SCHEMBL351872

SCHEMBL351872

CC(=O)OC(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17236094 1.00
SCHEMBL28010889 0.80
SCHEMBL27842795 0.80
SCHEMBL17078105 0.80
Hydrochloric Acid SCHEMBL18343842 0.78 LMNA (0.43)
Hydrochloric Acid SCHEMBL27585259 0.77 TSHR (0.46)
SCHEMBL359717 0.77
SCHEMBL16316794 0.77
SCHEMBL18225 0.77
SCHEMBL9906089 0.76 KMT2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103946217-B 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof 杭州本生药业有限公司 2017-04-19 CN claimed
US-20150344497-A1 PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO INCYTE CORPORATION (US) 2015-12-03 US claimed
CN-103946217-A 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO LTD 2014-07-23 CN claimed
US-4920129-A Anti-ulcerative imidazopyridine compounds FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-04-24 US claimed
US-4673676-A Pyrimidoisoquinoline derivatives useful for treating allergies FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-16 US claimed
EP-0143001-A2 Pyrimidoisoquinoline derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-05-29 EP claimed
US-10450325-B2 Processes of preparing a JAK1 inhibitor and new forms thereto INCYTE CORPORATION (US) 2019-10-22 US disclosed
US-20180099978-A1 PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO INCYTE CORPORATION 2018-04-12 US disclosed
US-9802957-B2 Processes of preparing a JAK1 inhibitor and new forms thereto INCYTE CORPORATION (US) 2017-10-31 US disclosed
CN-103946217-B 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof 杭州本生药业有限公司 2017-04-19 CN disclosed
EP-3137471-A1 PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO Incyte Corporation (US) 2017-03-08 EP disclosed
EP-2398766-B1 GERANYL LACTAMIDE AS FLAVOURING AGENT GIVAUDAN SA (CH) 2016-06-22 EP disclosed
US-20150344497-A1 PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO INCYTE CORPORATION (US) 2015-12-03 US disclosed
WO-1995017390-A1 N-SUBSTITUTED ARYL TRIFLUOROMETHYL IMIDAZOLES BAYER AKTIENGESELLSCHAFT (DE) 1995-06-29 WO disclosed
EP-0654024-A1 2-THIOINDOLES (SELENOINDOLES) AND RELATED DISULFIDES (SELENIDES) WHICH INHIBIT PROTEIN TYROSINE KINASES AND WHICH HAVE ANTITUMOR PROPERTIES WARNER-LAMBERT COMPANY (US) 1995-05-24 EP disclosed
WO-1994003427-A1 2-THIOINDOLES (SELENOINDOLES) AND RELATED DISULFIDES (SELENIDES) WHICH INHIBIT PROTEIN TYROSINE KINASES AND WHICH HAVE ANTITUMOR PROPERTIES WARNER-LAMBERT COMPANY (US) 1994-02-17 WO disclosed
US-4920129-A Anti-ulcerative imidazopyridine compounds FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-04-24 US disclosed
EP-0308917-A2 Imidazopyridine compound, a process for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-29 EP disclosed
US-4673676-A Pyrimidoisoquinoline derivatives useful for treating allergies FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-16 US disclosed
EP-0013067-A1 Bicyclic beta-lactam antibacterial agents, their use in pharmaceutical compositions, processes for their preparation and intermediates for use in such processes BEECHAM GROUP PLC (GB) 1980-07-09 EP disclosed